MARTIN HENTEMANN,JILL WOOD,WILLIAM SCOTT,MARTIN MICHELS,ANN-MARIE CAMPBELL,ANN-MARIE BULLION,R. BRUCE ROWLEY,ANIKO REDMAN
申请号：
HK16106013.2
公开号：
HK1217953A
申请日:
2016.05.26
申请国别(地区):
HK
年份:
2017
代理人:
摘要：
This invention relates to novel 2,3-dihydroimidazo[1,2-c]quinazoline compounds, pharmaceutical compositions containing such compounds and the use of those compounds or compositions for phosphotidylinositol-3-kinase (PI3K) inhibition and treating diseases associated with phosphotidylinositol-3-kinase (PI3K) activity, in particular treating hyper-proliferative and/or angiogenesis disorders, as a sole agent or in combination with other active ingredients.
